http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#Head http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#assertion http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#provenance http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#pubinfo http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#assertion http://purl.obolibrary.org/obo/MONDO_0007079 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0007079 http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB09072 http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association http://www.w3.org/2000/01/rdf-schema#label nly a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin, ondansetron, varenicline, baclofen, sodium oxybate and antidepressants. http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28658981/ http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication https://go.drugbank.com/drugs/DB09072 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#provenance http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#pubinfo http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#sig http://purl.org/nanopub/x/hasSignature en291PZzQL2v359m90wBX4Cu7QeAH/7q/Zzg/AHYiBOV2fCjGuubySL0VFqNflsvYN0KY4YVhIZCqWZLa4dVeSs5zuP0+vJe1wrW1/v21f+SfW+wLCZAKr2j/hq5W4Pz30a56ZxffJY4nsuoXiZtf0KhGgwogg4QGrAxi7dqCVk= http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://purl.org/dc/terms/created 2021-05-26T12:57:42.991+02:00 http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg